Profile of gantenerumab and its potential in the treatment of Alzheimer’s disease [Corrigendum]

MLA

Novakovic D, et al. “Profile of Gantenerumab and Its Potential in the Treatment of Alzheimer’s Disease [Corrigendum].” Drug Design, Development and Therapy, vol. 2014, May 2014, pp. 569–70. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doajarticles..fb865b64ffbbc9d4c732affe73939fab&authtype=sso&custid=ns315887.

APA

Novakovic D, Feligioni M, Scaccianoce S, Caruso A, Piccinin S, Schepisi C, Errico F, Mercuri NB, Nicoletti F, & Nisticò R. (2014). Profile of gantenerumab and its potential in the treatment of Alzheimer’s disease [Corrigendum]. Drug Design, Development and Therapy, 2014, 569–570.

Chicago

Novakovic D, Feligioni M, Scaccianoce S, Caruso A, Piccinin S, Schepisi C, Errico F, Mercuri NB, Nicoletti F, and Nisticò R. 2014. “Profile of Gantenerumab and Its Potential in the Treatment of Alzheimer’s Disease [Corrigendum].” Drug Design, Development and Therapy 2014 (May): 569–70. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doajarticles..fb865b64ffbbc9d4c732affe73939fab&authtype=sso&custid=ns315887.